other:Article Title: CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
Article Snippet: Primary antibodies included those against ACTB/β-actin (ABclonal Technology, AC026; 1:200000), POLR2A (ABclonal, A11181; 1:2000), p-POLR2A-S2(ABclonal, AP0749; 1:2000), CDK9 (Cell Signaling Technology, 2316; 1:2000), SIRT1 (Cell Signaling Technology, 2493; 1:2000), p-SIRT1 (Abcam, ab76039; 1:2000), FOXO3 (Proteintech, 66428-1-lg; 1:2000), BNIP3 (ABclonal, A5683; 1:2000), PINK1 (Cell Signaling Technology, 6946; 1:2000), PRKN/parkin (Cell Signaling Technology, 4211; 1:2000), TOMM20 (Proteintech, 11802-1-AP; 1:2000), COX4I1 (ABclonal, A6564; 1:2000), pan acetyl-lysine polyclonal antibody (ABclonal, A2391; 1:2000), and MAP1LC3A (Cell Signaling Technology, 4108; 1:2000).
Article Title: Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy.
Article Snippet: Primary antibodies included those against ACTB/ β-actin (ABclonal, AC026; 1:200000), SIRT1 (CST, D739, 1:2000), pan acetyl-lysine polyclonal antibody (ABclonal, A2391; 1:2000), GLUT1 (Proteintech, 21829–1-AP; 1:2000), PGC1-α (Proteintech, 66369–1-Ig; 1:2000), PDK2 (Proteintech, 15647–1-AP; 1:2000), GAPDH (ABclonal, AC002; 1:200000), Caspase-3 (ABclonal, A2156; 1:1000), Activecaspase-3 (ABclonal, A11021; 1:1000), OPA1 (ABclonal, A9833; 1:2000), OMA1 (ABclonal, A14437; 1:1000), YME1L1 (ABclonal, A10402; 1:2000), MFN1 (ABclonal, A9880; 1:2000), MFN2 (ABclonal, A12771; 1:2000), DRP1 (ABclonal, A2586; 1:2000), p-DRP1-S637 (ABclonal, AP0812; 1:1000), p-DRP1-S616 (ABclonal, AP1353; 1:1000), FIS1 (Proteintech, 66635–1-Ig; 1:2000), PARL (ABclonal, A8232; 1:2000), Caspase-9 (Abcam, ab202068; 1:2000).
Article Title: Ailanthone blocks mitophagy to promote mtDNA leakage through BAX-BAK1 pores and suppress hepatocellular carcinoma cell proliferation
Article Snippet: Primary antibodies included those against ACTB/β-Actin (ABclonal Technology, AC026; 1:200000), LC3-I/II (CST, 12741 1:1000), COX4I1 (Proteintech, 66110-1-Ig, 1:8000), PINK1 (CST, 6946, 1:1000), PRKN (CST, 4211, 1:1000), BAK1 (Proteintech, 29552-1-AP, 1:10000), BAX (Proteintech, 50599-2-lg, 1:10000), Ub (CST, 3,936, 1:1000), TNF-α (Proteintech, 60291-1-Ig, 1:8000), IL-1β (Proteintech, 16806-1-AP, 1:1000), IL-6 (Proteintech, 21865-1-AP, 1:1000).
|